LDL particle number and size and cardiovascular risk: anything new under the sun?

被引:30
作者
Allaire, Janie [1 ]
Vors, Cecile [1 ]
Couture, Patrick [1 ]
Lamarche, Benoit [1 ]
机构
[1] Univ Laval, Inst Nutr & Aliments Fonct, Ctr Rech, CHU Quebec, Quebec City, PQ, Canada
基金
加拿大健康研究院;
关键词
cardiovascular disease risk management; LDL particle number; LDL particle size; non-HDL-C; CORONARY-HEART-DISEASE; NON-HDL CHOLESTEROL; APOLIPOPROTEIN-B; LIPOPROTEIN SUBFRACTIONS; ION MOBILITY; PREVENTION; SOCIETY; DYSLIPIDEMIA; ASSOCIATION; DISCORDANCE;
D O I
10.1097/MOL.0000000000000419
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose of review We provide here an up-to-date perspective on the potential use of LDL particle number and size as complementary risk factors to predict and manage cardiovascular disease (CVD) risk in the clinical realm. Recent findings Studies show that a significant proportion of the population has discordant LDL particle number and cholesterol indices [non-HDL cholesterol (HDL-C)]. Data also show that risk prediction may be improved when using information on LDL particle number in patients with discordant particle number and cholesterol data. Yet, most of the current CVD guidelines conclude that LDL particle number is not superior to cholesterol indices, including non-HDL-C concentrations, in predicting CVD risk. LDL particle size, on the other hand, has not been independently associated with CVD risk after adjustment for other risk factors such as LDL cholesterol, triglycerides, and HDL-C and that routine use of information pertaining to particle size to determine and manage patients' risk is not yet justified. Summary Additional studies are required to settle the debate on which of cholesterol indices and LDL particle number is the best predictor of CVD risk, and if such measures should be integrated in clinical practice.
引用
收藏
页码:261 / 266
页数:6
相关论文
共 30 条
[1]   2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult [J].
Anderson, Todd J. ;
Gregoire, Jean ;
Pearson, Glen J. ;
Barry, Arden R. ;
Couture, Patrick ;
Dawes, Martin ;
Francis, Gordon A. ;
Genest, Jacques ;
Grover, Steven ;
Gupta, Milan ;
Hegele, Robert A. ;
Lau, David C. ;
Leiter, Lawrence A. ;
Lonn, Eva ;
Mancini, G. B. John ;
McPherson, Ruth ;
Ngui, Daniel ;
Poirier, Paul ;
Sievenpiper, John L. ;
Stone, James A. ;
Thanassoulis, George ;
Ward, Richard .
CANADIAN JOURNAL OF CARDIOLOGY, 2016, 32 (11) :1263-1282
[2]  
AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
[3]   Association of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins A Meta-analysis [J].
Boekholdt, S. Matthijs ;
Arsenault, Benoit J. ;
Mora, Samia ;
Pedersen, Terje R. ;
LaRosa, John C. ;
Nestel, Paul J. ;
Simes, R. John ;
Durrington, Paul ;
Hitman, Graham A. ;
Welch, K. M. A. ;
DeMicco, David A. ;
Zwinderman, Aeilko H. ;
Clearfield, Michael B. ;
Downs, John R. ;
Tonkin, Andrew M. ;
Colhoun, Helen M. ;
Gotto, Antonio M., Jr. ;
Ridker, Paul M. ;
Kastelein, John J. P. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (12) :1302-1309
[4]   Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis [J].
Caulfield, Michael P. ;
Li, Shuguang ;
Lee, Gloria ;
Blanche, Patricia J. ;
Salarneh, Wael A. ;
Benner, W. Henry ;
Reitz, Richard E. ;
Krauss, Ronald M. .
CLINICAL CHEMISTRY, 2008, 54 (08) :1307-1316
[5]   Association of Apolipoprotein B and Nuclear Magnetic Resonance Spectroscopy-Derived LDL Particle Number with Outcomes in 25 Clinical Studies: Assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices [J].
Cole, Thomas G. ;
Contois, John H. ;
Csako, Gyorgy ;
McConnell, Joseph P. ;
Remaley, Alan T. ;
Devaraj, Sridevi ;
Hoefner, Daniel M. ;
Mallory, Tonya ;
Sethi, Amar A. ;
Warnick, G. Russell .
CLINICAL CHEMISTRY, 2013, 59 (05) :752-770
[6]   LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study-Implications for LDL management [J].
Cromwell, William C. ;
Otvos, James D. ;
Keyes, Michelle J. ;
Pencina, Michael J. ;
Sullivan, Lisa ;
Vasan, Ramachandran S. ;
Wilson, Peter W. F. ;
D'Agostino, Ralph B. .
JOURNAL OF CLINICAL LIPIDOLOGY, 2007, 1 (06) :583-592
[7]   Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3) [J].
Deanfield, John ;
Simpson, Iain ;
Bradbury, Kirsten ;
Fox, Keith ;
Boon, Nick ;
Winocour, Peter ;
Feher, Michael ;
Doherty, Patrick ;
Buckley, John ;
Jennings, Catriona ;
Keenan, Jan ;
Weissberg, Peter ;
Knapton, Mike ;
Williams, Bryan ;
Poulter, Neil ;
Stevens, Paul ;
Taal, Maarten ;
Grant, Peter ;
Home, Philip ;
Sattar, Naveed ;
Rees, Alan ;
Neely, Dermot ;
Wheeler, David ;
Goldsmith, David ;
Potter, John ;
Jackson, Stephen .
HEART, 2014, 100 :1-67
[8]   The composition and metabolism of large and small LDL [J].
Diffenderfer, Margaret R. ;
Schaefer, Ernst J. .
CURRENT OPINION IN LIPIDOLOGY, 2014, 25 (03) :221-226
[9]  
Goff DC, 2014, CIRCULATION, V129, pS49, DOI [10.1161/01.cir.0000437741.48606.98, 10.1016/j.jacc.2013.11.005]
[10]   Cost Effectiveness of Achieving Targets of Low-Density Lipoprotein Particle Number Versus Low-Density Lipoprotein Cholesterol Level [J].
Grabner, Michael ;
Winegar, Deborah A. ;
Punekar, Rajeshwari S. ;
Quimbo, Ralph A. ;
Cziraky, Mark J. ;
Cromwell, William C. .
AMERICAN JOURNAL OF CARDIOLOGY, 2017, 119 (03) :404-409